EU research funding
The European Commission website on COVID-19 contains an overview of initiatives and calls made in the EU.
To the European Commission
To Funding & tender opportunities concerning COVID-19
To MSCA Community concerning COVID-19
How are EU projects and applications affected?
These pages contain information about, among other things, postponed project start, flexibility for timesheet, and delays in submitting reports due to COVID-19.
Read more about Grant management under COVID-19
Questions and answers from NCP
- Always contact the Project Officer first
The Project Officers at the European Commission will look at each case individually and as soon as possible.
- ERA Corona Platform
The portal contains an ERA Corona Platform. Click the tab "Search funding & tenders" to view it.
- Call deadlines
The platform will be filled with a table of calls with modified deadlines.
- Evaluation and monitoring of calls
All follow up and evaluation will take place online. Any costs for travel and equivalent that evaluators have/had may be reimbursed, but first, please check with the insurance company.
- Tenders (PCPs)
Tender projects can, just like subcontracting and good works and services, become a problem. The European Commission will be looking at this from case to case. What does the tender contract state? What part of the project is experiencing these problems?
- Does the supplier need more time? Submit an amendment.
- Do you need to stop all activity in the project? In that case, use suspension (all activities on hold).
- If everything is at a standstill due to COVID-19 restrictions, please apply for project extension for the crisis period on EU level and contact the Project Officer.
- Can a project start be postponed?
Yes, it is an option.
- Project start later on > Change date.
- Already signed GA > Amendment and change date.
- Project has been started > Work remotely, request an extension or suspension of the implementation via amendment. Please note! This could mean that some costs cannot be replaced.
- Timesheet signature
Paper > Wait until current restrictions have eased, but keep check on what work is done.
Digital > Cannot be signed due to restrictions of working remotely and similar. 1) Scan information/photograph. 2) Send the information to your supervisor for signature via email. Save everything. This will form basis for your digital timesheet.
- Certificate on Financial Statements (CFS)
Under COVID-19 circumstances, funding bodies will make final payments even if beneficiaries cannot hand in a certificate on financial statement (CFS) with their final report (see article 20.4, H2020 MGA). The amount, however, will be limited to the threshold of the CFS of EUR 324,999.
Beneficiaries will receive additional payments when handing in their CFS for the remaining sum covered by the certificate. If a final report is not complete due to other aspects (e.g. that certain tasks have not been completed), the coordinators can request an amendment of up to 6 months to complete the tasks (see FAQ on Project duration). Beneficiaries must still hand in their CFS together with the final report at a later stage.
- Link to COVID-19 FAQ, European Commission
International research funding and resources
Forska!Sverige has listed all international funding opportunities as well as resources for research and innovation regarding SARS-CoV-2 and COVID-19.
See the full list
Major collaboration over new data portal for COVID-19
 Over 73,000 users are already collaborating on a new online platform set up by the European Open Science Cloud Initiative. Here, as a researcher, you can share COVID-19 data, accelerate our understanding of the virus, and thus contribute to a faster development of treatments.
Read the news article
Go directly to the COVID-19 Data Portal
National research funding
The Swedish Research Council is opening up for COVID-19 research
 If you have a grant from the Swedish Research Council, you can now use part of your funding for research related to Sars-CoV-2 and COVID-19 for a limited period – regardless of what project the funds were granted for initially.
Go to the Swedish Research Council
Another eight million to support clinical studies relating to COVID-19
 The six regional nodes within Clinical Studies Sweden will receive an additional 8 million SEK in total to further expand their abilities to support clinical studies linked to COVID-19.
Read more on the Swedish Research Council's website
50 million for further research on COVID-19
 The Knut and Alice Wallenberg Foundation is allocating an additional 50 million SEK to COVID-19-related research in 2021 and 2022. The purpose is to promote the production of useful data and knowledge about the Corona pandemic, both now, and as a basis for adressing any future pandemics we might face.
Read the entire news article
SEK 40 million for research on COVID-19 vaccine
 Several new vaccines will be available for use starting early 2021. Now, Knut and Alice Wallenberg Foundation has allocated SEK 40 million to SciLifeLab for research on the efficacy and function of COVID-19 vaccines.
Read the press release
Call for proposals – COVID-19 pandemic research and preparedness
 SciLifeLab, with support from Knut and Alice Wallenberg Foundation, now seeks proposals within five calls on COVID-19 research:
- Proposals from existing research areas (RAs) in the SciLifeLab-KAW COVID-19 program
- Proposals from individual scientists with new contributions to the SciLifeLab-KAW COVID-19 research program
- New KAW supported COVID-19 research program on vaccine effects
- Laboratory preparedness for pandemics
- Data-driven life science (DDLS) on COVID-19
Deadline for call 1–3 and call 5 is January 15, 2021.
Deadline for Call 4 is January 31, 2021.
Read more about the calls and apply
Upcoming call: Research environment grant for follow-up studies of COVID-19 vaccines
 On 23 March, the Swedish Research Council will open a call in order to give researchers the opportunity to collaborate nationally to conduct follow-up studies of COVID-19 vaccines. For example, when it comes to the protective effect and safety of approved vaccines over the long and short term, for different age, risk and patient groups, or for the general population. The deadline for applying is set to 13 April.
Read the advance information
How are national projects and applications affected?
The national research funding bodies are affected by the coronavirus just like other organisations – and they are well aware that conditions change also for researchers. Please visit the funding bodies' websites to learn what happens to tenders and preparation work.
The Research Support and Collaboration Office is continuously updating this webpage.